z-logo
open-access-imgOpen Access
Characterisation of bacteria in ascites—reporting the potential of culture-independent, molecular analysis
Author(s) -
Geraint B. Rogers,
Lloyd Russell,
P. G. Preston,
Peter Marsh,
Jane Collins,
John Saunders,
John Sutton,
David Fine,
K.D. Bruce,
Mark Wright
Publication year - 2010
Publication title -
european journal of clinical microbiology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.154
H-Index - 106
eISSN - 1435-4373
pISSN - 0934-9723
DOI - 10.1007/s10096-010-0891-5
Subject(s) - medical microbiology , ascites , bacteria , microbiology and biotechnology , computational biology , medicine , biology , intensive care medicine , genetics
Spontaneous bacterial peritonitis (SBP) is a severe complication of liver disease. A significant proportion of patients have culture-negative ascites, despite having similar signs, symptoms and mortality to those with SBP. Therefore, empirical antibiotic treatment for infection is often started without knowledge of the causative organisms. Here, we investigated the potential of molecular techniques to provide rapid and accurate characterisation of the bacteria present in ascitic fluid. Ascites samples were obtained from 29 cirrhotic patients undergoing clinically indicated therapeutic paracentesis. Bacterial content was determined by terminal restriction fragment length polymorphism (T-RFLP) analysis, quantitative polymerase chain reaction (PCR) and 16S ribosomal clone sequence analysis. Bacterial signal was detected in all samples, compared to three out of ten using standard methods. Bacterial loads ranged from 5.5 x 10(2) to 5.4 x 10(7) cfu/ml, with a mean value of 1.9 x 10(6) cfu/ml (standard deviation +/- 9.6 x 10(6) cfu/ml). In all but one instance, bacterial species identified by culture were also confirmed by molecular analyses. Preliminary data presented here suggests that culture-independent, molecular analyses could provide rapid characterisation of the bacterial content of ascites fluid, providing a basis for the investigation of SBP development and allowing early and targeted antibiotic intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom